Literature DB >> 1864634

Cell-mediated immune functions in a patient with MHC class II deficiency.

J W Mannhalter1, H M Wolf, H Gadner, M Potschka, M M Eibl.   

Abstract

This report focuses on cell-mediated immune functions in a patient with MHC class II deficiency. The patient described presented with a case of "classical" MHC class II deficiency (T and B cells within the normal range, normal lymphocyte proliferation in response to stimulation with mitogens, gene encoding for MHC class II present, no expression of MHC class II). The absence of MHC class II expression resulted in an incapability of the patient's antigen-presenting cells to function as accessory cells in the presentation of soluble protein antigens, while accessory functions required for the induction of alloantigen-induced lymphocyte proliferation or for the generation of cytotoxic T cells in response to an allostimulus were normal. The patient's T cells responded normally to alloantigenic stimulation and also had the capacity to develop antigen-specific cytotoxic functions. However, the T cells were completely naive with respect to activation by soluble protein antigens, even after presentation by accessory cells derived from the patient's healthy histoidentical brother. In this context it was interesting to note that the patient's CD4-positive cells showed a normal pattern of expression of the 4B4 marker, a marker generally present on memory T cells. These data make it tempting to speculate that in the absence of MHC class II, other cell surface structures may at least partially take over immune functions normally under the control of the MHC class II complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864634     DOI: 10.3109/08820139109050783

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  3 in total

1.  T cell differentiation and generation of the antigen-specific T cell repertoire in man: observations in MHC class II deficiency.

Authors:  J W Mannhalter; H M Wolf; I Hauber; M Miricka; H Gadner; M M Eibl
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

2.  Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.

Authors:  B Durand; M Kobr; W Reith; B Mach
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

3.  Hypoxemic Bronchiolitis Related to Major Histocompatibility Class II Deficiency.

Authors:  S Hammami; H Besbès; S Hadded; K Lajmi; L Ghédira; Ch B Meriem; M N Guediche
Journal:  Case Rep Med       Date:  2013-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.